SCHEMBL572925

SCHEMBL572925

CCCCNc1cc(C(=O)OC)cc(S(=O)(=O)N=CN(C)C)c1Oc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.59
▸ USP2 O75604 1/20 0.59
▸ ALDH1A1 P00352 1/20 0.59
▸ CA2 P00918 1/20 0.59
▸ LMNA P02545 1/20 0.59
▸ HPGD P15428 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ BLM P54132 1/20 0.59
▸ SLC12A2 P55011 1/20 0.59
▸ HIF1A Q16665 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ HSD17B10 Q99714 1/20 0.59
▸ AQP1 P29972 1/20 0.51
▸ PTGS2 P35354 16/20 0.50
▸ HDAC3 O15379 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10222976 1.00 KDM4E (0.59) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL572924 1.00 KDM4E (0.59) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL21454165 0.85 KDM4E (0.52) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL21436751 0.85 KDM4E (0.52) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL21436750 0.85 KDM4E (0.52) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL573942 0.85 KDM4E (0.66) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL10222977 0.84 LMNA (0.40) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL574196 0.84 ALDH1A1 (0.40) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL574197 0.84 ALDH1A1 (0.40) KDM4EUSP2ALDH1A1CA2LMNA
SCHEMBL14879573 0.84 KDM4E (0.69) KDM4EUSP2ALDH1A1CA2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
Send feedback